Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ZG-801 randomized withdrawal trial in hyperkalemia
jRCT2031210188Phase 3Completed
- Sponsor
- Zeria Pharmaceutical Co., Ltd.
- Start
- Aug 2021
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of patiromer in hyperkalemia (3 arms), sponsored by Zeria Pharmaceutical Co., Ltd. Started Aug 2021; status: completed.
02
Drugs
patiromer
03
Conditions
hyperkalemia
Beyond the preview
Go deeper on jRCT2031210188.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031210188.